Laser Skin Resurfacing

Laser skin resurfacing can reduce facial wrinkles, scars and blemishes. Newer laser technologies allow plastic surgeons a new level of control in laser surfacing, permitting extreme precision, especially in delicate areas. It is all about using beams of light. Laser skin resurfacing also involves a laser peel, laser vaporization or lasabrasion. The surgeon uses the laser to send short, concentrated pulsating beams of light directed at irregular skin, which removes unwanted, damaged skin in a very precise manner, one layer at a time. This targeted approach means there are fewer problems with hypopigmentation, or a lightening of skin, in procedures like laser acne scar removal. In laser resurfacing, the laser removes the outer layer of skin, called the epidermis. It simultaneously heats the underlying skin, called the dermis. This action works to stimulate growth of new collagen fibers. As the treated area heals, the new skin that forms is smoother and firmer. Laser resurfacing can improve minor facial flaws such as fine lines or wrinkles around or under the eyes, forehead or mouth. It treats aged and sun-damaged skin. Laser resurfacing improves the complexion of the patient especially if he or she has yellowish or grayish skin tones.

More Resources

INVESTMENT INTERESTS

SEC. 6002. TRANSPARENCY REPORTS AND REPORTING OF PHYSICIAN
OWNERSHIP OR INVESTMENT INTERESTS.
Part A of title XI of the Social Security Act (42 U.S.C. 1301 et
seq.) is amended by inserting after section 1128F the following new
section:
  SEC. 1128G o42 U.S.C. 1320a–7h.. TRANSPARENCY REPORTS AND REPORTING
OF PHYSICIAN OWNERSHIP OR INVESTMENT INTERESTS.
(a) TRANSPARENCY REPORTS.—
(1) PAYMENTS OR OTHER TRANSFERS OF VALUE.—
(A) IN GENERAL.—On March 31, 2013, and on the
90th day of each calendar year beginning thereafter, any
applicable manufacturer that provides a payment or other
transfer of value to a covered recipient (or to an entity or
individual at the request of or designated on behalf of a
covered recipient), shall submit to the Secretary, in such
electronic form as the Secretary shall require, the following
information with respect to the preceding calendar
year:
(i) The name of the covered recipient.
(ii) The business address of the covered recipient
and, in the case of a covered recipient who is a physician,
the specialty and National Provider Identifier of
the covered recipient.
(iii) The amount of the payment or other transfer
of value.
(iv) The dates on which the payment or other
transfer of value was provided to the covered recipient.
(v) A description of the form of the payment or
other transfer of value, indicated (as appropriate for
all that apply) as—
(I) cash or a cash equivalent;
(II) in-kind items or services;
(III) stock, a stock option, or any other ownership
interest, dividend, profit, or other return on
investment; or
(IV) any other form of payment or other
transfer of value (as defined by the Secretary).
(vi) A description of the nature of the payment or
other transfer of value, indicated (as appropriate for
all that apply) as—
(I) consulting fees;
(II) compensation for services other than consulting;
(III) honoraria;
(IV) gift;
(V) entertainment;
(VI) food;
(VII) travel (including the specified destinations);
(VIII) education;
(IX) research;
(X) charitable contribution;
(XI) royalty or license;
(XII) current or prospective ownership or investment
interest;
(XIII) direct compensation for serving as faculty
or as a speaker for a medical education program;
(XIV) grant; or
(XV) any other nature of the payment or
other transfer of value (as defined by the Secretary).
(vii) If the payment or other transfer of value is
related to marketing, education, or research specific to
a covered drug, device, biological, or medical supply,
the name of that covered drug, device, biological, or
medical supply.
(viii) Any other categories of information regarding
the payment or other transfer of value the Secretary
determines appropriate.